Nektar Therapeutics NKTR Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Nektar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nektar Therapeutics's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nektar Therapeutics's interest income?
- Nektar Therapeutics (NKTR) reported interest income of $4.24M in Q1 2026.
- How has Nektar Therapeutics's interest income changed year-over-year?
- Nektar Therapeutics's interest income increased by 47.6% year-over-year, from $2.87M to $4.24M.
- What is the long-term trend for Nektar Therapeutics's interest income?
- Over 4 years (2021 to 2025), Nektar Therapeutics's interest income has grown at a 39.8% compound annual growth rate (CAGR), from $2.73M to $10.44M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.